SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001232524-18-000196
Filing Date
2018-11-19
Accepted
2018-11-19 17:32:56
Documents
1
Period of Report
2018-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 9123
  Complete submission text file 0001232524-18-000196.txt   10591
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 45 FITZWILLIAM SQUARE DUBLIN L2 2
Business Address
Mulligan Seamus (Reporting) CIK: 0001536639 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 181193593